Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening

Journal of Diabetes & Metabolic Disorders

Seyed Mahmoud Latifi²  Hajie Bibi Shahbazian²  Kourosh Zarea¹  Shahram Baraz¹ 

[1] Chronic Diseases Care Research Center, School of Nursing and Midwifery, Ahvaz Jundishapur University of Medical Sciences (AJUMS), Golestan Street, Ahvaz, Iran;Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

关键词: Iran;    Nerve conduction velocity;    Screening;    Monofilament;    Diabetes;    Peripheral sensory neuropathy;   

Others  :  806344
DOI  :  10.1186/2251-6581-13-19

 received in 2013-09-07, accepted in 2013-12-19,  发布年份 2014

【 摘 要 】

Background

Diabetic Peripheral Neuropathy is one of the most prevalent complications of diabetes mellitus. The development and progression of such complications are responsible for much of the morbidity and mortality. The purpose of this study was to evaluate the effectiveness of Semmes–Weinstein monofilament ten gram in 3, 4, eight and ten points in the screening of diabetic peripheral neuropathy in patients with diabetes mellitus.

Methods

In a descriptive correlational design, 150 patients with diabetes mellitus were selected using convenience sampling. All patients were evaluated for sensory neuropathy using ten gram Semmes-Weinstein Monofilaments and questionnaire on neuropathy symptoms. In the next phase, nerve conduction velocity was examined. The most common subjective symptoms were paresthesia of both feet, pain in feet, burning sensation in the extremities and numbness in the extremities.

Results

The results showed that the sensitivity of Monofilament in three and four points were 35.9 to 53.8 present and 38.5 to 51.3 percent respectively. Specificity of Monofilament the same points, were 73.9 to 84.7 and 73 to 87.4 percent respectively. Monofilament sensitivity at eight and ten points were 38.5 to 61.5 and 64.1 to 30.8 percent respectively. Also, specificity of the same points were 77.5 to 95.5 and 64 to 89.2 percent respectively. It was revealed that the difference sensitivity and specificity of Monofilament in three and four points with sensitivity and specificity in eight and ten point is not statistically significant.

Conclusions

This study showed that Semmes-Weinstein monofilament can easily use as a simple and inexpensive device for screening. Since increasing the number of points it was not significantly difference. Therefore, we suggest that screening for diabetic peripheral neuropathy, especially in large populations to avoid wasting time on Monofilament application, areas like three or four points eight and ten points could be used.

【 授权许可】

   
2014 Baraz et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Sicree R, Shaw J, Zimmet P: Diabetes and impaired glucose tolerance: Delice Gan diabetes atlas. 3rd edition. Brussels, Belgium: International Diabetes Federation; 2007.
• [2]Larijani B: Hasani-Ranjbar s: overview of diabetic foot; novel treatments in diabetic foot ulcer. Daru 2008, 16(suppl 1):1-6.
• [3]Booya F, Bandarian F, Larijani B, Pajouhi M, Nooraei M, Lotfi J: Potential risk factors for diabetic neuropathy: a case control study. BMC Neurol 2005, 10(5):24.
• [4]Hunt D: Using evidence in practice. Foot care in diabetes. Endocrinol Metab Clin North Am 2002, 31(3):603-611.
• [5]Janghorbani M, Rezvanian H, Kachooei A, Ghorbani A, Chitsaz A, Izadi F, Amini M: Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors. Acta Neurol Scand 2006, 114(6):384-391.
• [6]Lavery LA, Lavery DE, Lavery DC, LaFontaine J, Bharara M, Najafi B: Accuracy and durability of Semmes–Weinstein monofilaments: what is the useful service life? Diabetes Res Clin Pr 2012, 97(3):399-404.
• [7]Aliasgharpour M, Nayeri ND: The care process of diabetic foot ulcer patients: a qualitative study in Iran. J Diab Metab Disorders 2012, 11(1):27. BioMed Central Full Text
• [8]Pajouhi M, Shaban Nejad Khas Z, Mohajeri Tehrani M: Evaluation and prevention of diabetic neuropathy (review article). TUMJ 2007, 65(3):1-6.
• [9]Bruce G, Young T: Prevalence and risk factors for neuropathy in a Canadian first Nation community. Diab Care 2008, 31:1837-1841.
• [10]Aaberg M, Burch D, Hud Z, Zacharias M: Gender differences in the onset of diabetic neuropathy. J Diabetes Complications 2008, 22(2):83-87.
• [11]Malgrange D, Richard JL, Leymarie F: Screening diabetic patients at risk for foot ulceration. A multi-centre hospital-based study in France. Diab Metab 2003, 29(3):261-268.
• [12]Feng Y, Schlösser FJ, Sumpio BE: The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. J Vasc Surg 2009, 50(3):675-682. e671
• [13]Modawal A, Fley J, Shukla R, Rudawsky D, Welge J, Yang J: Use of monofilament in the detection of foot lesions in older adults. J Foot Ankle Surg 2006, 45(2):76-81.
• [14]Kamei N, Yamane K, Nakanishi S, Yamashita Y, Tamura T, Ohshita K, Watanabe H, Fujikawa R, Okubo M, Kohno N: Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 2005, 19(1):47-53.
• [15]Jurado J, Ybarra J, Pou JM: Isolated use of vibration perception thresholds and Semmes-Weinstein monofilament in diagnosing diabetic polyneuropathy: “The North Catalonia Diabetes Study”. Nursing Clinics of North America 2007, 42(1):59-66.
• [16]Litzelman D, Marriott D, Vinicor F: The role of footwear in the prevention of foot lesions in patients with NIDDM. Diab Care 1997, 20:156-162.
• [17]Litzelman D, Marriott D, Vinicor F: Independent physiological predictors of foot lesions in patients with NIDDM. Diab Care 1997, 20:1273-1278.
• [18]Birke J, Rolfsen R: Evaluation of a self-administered sensory testing tool to identify patients at risk of diabetes-related foot. Diab Care 1998, 21:23-25.
• [19]Suico J, Marriott D, Vinicor F, Litzelman D: Behaviors predicting foot lesions in patients with non-insulin-dependent diabetes mellitus. J Gen Intern Med 1998, 13:482-484.
• [20]Aalaa M, Malazy OT, Sanjari M, Peimani M, Mohajeri-Tehrani M: Nurses’ role in diabetic foot prevention and care; a review. J Diab Metab Disorders 2012, 11(1):24. BioMed Central Full Text
• [21]Rahman M, Griffin SJ, Rathmann W, Wareham NJ: How should peripheral neuropathy be assessed in people with diabetes in primary care? A population-based comparison of four measures. Diab Med 2003, 20:368-374.
• [22]Olaleye D, Perkins BA, Bril V: Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diab Res Clin Prac 2001, 54(2):115-128.
• [23]Miranda-palma B, Sosenko JM, Bowker JH, Mizel MS, Boulton AJM: A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diab Res Clin Prac 2005, 70:8-12.
• [24]Nather A, Neo S, Chionh S, Liew S, Sim E, Chew J: Assessment of sensory neuropathy in diabetic patients without diabetic foot problems. J Diabetes Complications 2008, 22(2):126-131.
• [25]Ylitalo KR, Herman WH, Harlow SD: Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucose. Primary Care Diabetes 2013, 7(4):309-313.
• [26]Young M, Boulton A, McLeod A, Williams D, Sonksen P: A multicentre study of the prevalence of diabetic peripheral neuropathy in a United Kingdom hospital clinic population. Diabetologia 1993, 36:150-154.
• [27]Abbott AL, Carrington H, Ashe S, Bath LC, Every J, Griffiths ER, Van Ross AJM: Boulton, North–west diabetes foot care study: incidence of and risk factors for new diabetic foot ulceration in a community-based study. Diab Med 2002, 19:377-384.
• [28]Griffiths ER, Van Ross AJM: Boulton, North–west diabetes foot care study: incidence of and risk factors for new diabetic foot ulceration in a community-based study. Diab Med 2002, 19:377-384.
• [29]Forouzandeh F, Aziz Ahari A, Abolhasani F, Larijani B: Comparison of different screening tests for detecting diabetic foot neuropathy. Acta Neurologica Scandinavica 2005, 112(6):409-413.
• [30]Mason J, O’Keeffe C, McIntosh A, Hutchinson A, Booth A, Young R: A systematic review of foot ulcer in patients with type 2 diabetes mellitus. I. Prevention. Diabet Med 1999, 16(10):799-800.
• [31]Shin J, Seong Y, Lee H, Kim S, Suk H, Lee Y: The usefulness of minimal F-wave latency and sural/radial amplitude ratio in diabetic polyneuropathy. Yonsei Med J 2000, 41:393-397.
• [32]Olmos PR, Cataland S, O’Dorisio TM, Casey CA, Smead WL, Simon S: The Semmes-Weinstein monofilament as a potential predictor of foot ulceration in patients with noninsulin-dependent diabetes. Am J Med Sci 1995, 309:76-82.
• [33]Dimitrakoudis D, Bril V: Comparison of sensory testing on different toe surfaces: implications for neuropathy screening. Neurology 2002, 59(4):611-613.
• [34]Abouaesha F, van Schie CHM, Griffths GD, Young RJ, Boulton AJM: Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care 2001, 24(7):1270-1274.